4//SEC Filing
Lavelle Erin 4
Accession 0001209191-22-029323
CIK 0001404644other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 6:23 PM ET
Size
9.2 KB
Accession
0001209191-22-029323
Insider Transaction Report
Form 4
Lavelle Erin
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-05-12+25,000→ 25,000 totalExercise: $1.07Exp: 2032-05-11→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The option vests as to 1/12 of the total shares monthly beginning June 12, 2022 until the option is fully vested on May 12, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Documents
Issuer
Neoleukin Therapeutics, Inc.
CIK 0001404644
Entity typeother
Related Parties
1- filerCIK 0001737613
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 6:23 PM ET
- Size
- 9.2 KB